• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SET 15 CM (6 IN) 1.14 ML STD BORE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SET 15 CM (6 IN) 1.14 ML STD BORE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385101
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/30/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Date of event is unknown; awareness date has been used for this field.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd q-syte extension set 15 cm (6 in) 1.14 ml std bore leakage occurred.The following information was provided by the initial reporter: leakage from marked point.
 
Additional Manufacturer Narrative
Date of event is unknown; awareness date has been used for this field.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd q-syte extension set 15 cm (6 in) 1.14 ml std bore leakage occurred.The following information was provided by the initial reporter: leakage from marked point.
 
Event or Problem Description
It was reported while using bd q-syte extension set 15 cm (6 in) 1.14 ml std bore leakage occurred.The following information was provided by the initial reporter: leakage from marked point.
 
Additional Manufacturer Narrative
H6: investigation summary our quality engineer inspected the 1 photo submitted for evaluation.The reported issue was not confirmed upon inspection of the photo.No damages or defects that could have contributed to a leakage failure were observed in the photo.It is necessary for the used sample to be returned to properly investigate the reported failure.Bd cannot confirm the cause of the failure to our manufacturing process since no sample was returned for evaluation.A device history record review showed no non-conformances associated with this issue during the production of this batch.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.H3 other text : see h10.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 2022-03-04.Investigation summary: our quality engineer inspected the 1 sample submitted for evaluation.The reported issue was not confirmed upon testing of the sample.The sample underwent our internal leakage testing and no signs of leakage were observed.Bd cannot confirm a manufacturing related root cause of the failure since the reported defect was not confirmed during testing.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Event or Problem Description
It was reported while using bd q-syte extension set 15 cm (6 in) 1.14 ml std bore leakage occurred.The following information was provided by the initial reporter: leakage from marked point.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE EXTENSION SET 15 CM (6 IN) 1.14 ML STD BORE
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13319719
Report Number9610847-2022-00019
Device Sequence Number4886087
Product Code FPA
UDI-Device Identifier30382903851011
UDI-Public30382903851011
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K142527
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date03/31/2026
Device Model Number385101
Device Catalogue Number385101
Device Lot Number1082694
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/30/2021
Supplement Date Received by Manufacturer02/10/2022
03/22/2022
Initial Report FDA Received Date01/21/2022
Supplement Report FDA Received Date02/22/2022
04/08/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/28/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-